Upcoming Meetings: Obstetrics and Gynecology Devices Panel
This article was originally published in The Gray Sheet
Executive Summary
Obstetrics and Gynecology Devices Panel: Slated to meet Oct. 6-7 at FDA's corporate building in Rockville, Maryland. On Oct. 6 the panel will discuss a premarket approval application for Gynecare's ThermaChoice Uterine Balloon Therapy system for the treatment of excessive menstrual bleeding. On Oct. 7 the panel will discuss a petition for the reclassification of home uterine activity monitors from Class III to Class II. For further information contact FDA's Elisa Harvey at 301/594-1180...